Patients with COPD lung cancer need to receive VATS lobectomy
Conditions
Interventions
Experimental group:Beclometasone Dipropionate Suspension for Inhalation
Sponsors
Tianjin Chest Hospital
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients understand the test procedures and the risks involved in the test, and voluntarily sign informed consent to participate; 2. Patients with newly diagnosed or existing COPD (according to the standard of "guidelines for diagnosis and treatment of COPD 2013 revision"), with FEV1 =90%; 7. Hemoglobin >=100G/L; 8. The estimated operation time is <=4 hours.
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating women; 2. Patients need pneumonectomy or intraoperative frozen pathology suggesting benign; 3. The patient had a history of acute exacerbation of COPD within 3 months before the visit; 4. The patient has a history of asthma; 5. The patient had pneumonia within 1 month before the visit; 6. The patient had a history of cerebral infarction, myocardial infarction, heart failure, severe arrhythmia and tuberculosis within 6 months before the visit; 7. Confirmed or suspected HIV infection; 8. The patient has cataract and glaucoma; 9. Allergy to any experimental drug or excipient; 10. The patient participated in any other study trial within 30 days prior to visit 1; 11. In the investigator's judgment, there are any diseases or conditions that may pose a risk to the patient or hinder participation in the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of pulmonary complications (PPC); | — |
Countries
China
Contacts
Public ContactXun zhang
Tianjin Chest Hospital
Outcome results
None listed